VITREX MEDICAL A/S: Financial statements 2018
CVR: 14728732
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 25,131,412 and a net result of DKK 8,696,348 compared with DKK 6,400,477 the year before. That is an increase of 11.7% compared with the year before. Equity in the 2018 report amounted to DKK 25,782,280. The solvency ratio was 58.3%.
- Gross Profit
- DKK 25,131,412
- Profit/Loss
- DKK 8,696,348
- Equity
- DKK 25,782,280
- Total Assets
- DKK 44,260,796
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 25.1M | 8.7M | 25.8M | - |
| 2017 | - | 22.5M | 6.4M | 22.1M | - |
| 2016 | - | 20.6M | 5.1M | 20.7M | - |
| 2015 | - | 21.2M | 6.2M | 20.6M | - |
| 2014 | - | 16M | 4.6M | 17.9M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
VITREX MEDICAL A/S has published its annual report for 2017. Gross profit came to DKK 22,491,140, and the net result was DKK 6,400,477.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.